Author: Persica Pharmaceuticals

Posted Date:

March 23, 2026

Persica Pharmaceuticals Appoints Dr Edward Littler as Executive Chairman and David Watson as Chief Executive Officer

Persica Pharmaceuticals

March 23, 2026
Persica Pharmaceutical’s PP353 Phase 1b Data Selected for Oral Presentation at the American Society of Interventional Pain Physicians (ASIPP) 2026 Annual Meeting

Persica Pharmaceuticals

March 19, 2026
Persica Pharmaceuticals’ Positive Clinical Data for PP353 Treatment of Chronic Low Back Pain Published in The Lancet’s eClinicalMedicine

Persica Pharmaceuticals

February 3, 2026